
Immunovant, Inc.
Immunovant, Inc. (IMVT)
WebsitePrice
Market cap
Next catalystNCT07018323 topline results in 2027IMVT-1402 — Graves' disease studies · Data readoutSEC filing ↗
Cash
Chart & Events
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
History / paused
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved